IGM Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGMS and other ETFs, options, and stocks.

About IGMS

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies.

CEO

Mary Beth Harler

CEOMary Beth Harler

Employees

149

Employees149

Headquarters

Mountain View, California

HeadquartersMountain View, California

Founded

2010

Founded2010

Employees

149

Employees149

IGMS Key Statistics

Market cap

79.50M

Market cap79.50M

Price-Earnings ratio

-0.42

Price-Earnings ratio-0.42

Dividend yield

—

Dividend yield—

Average volume

195.35K

Average volume195.35K

High today

$1.40

High today$1.40

Low today

$1.31

Low today$1.31

Open price

$1.35

Open price$1.35

Volume

139.95K

Volume139.95K

52 Week high

$22.50

52 Week high$22.50

52 Week low

$0.92

52 Week low$0.92

IGM Biosciences

Why Robinhood?

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. Show more

IGMS Key Statistics

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies.